期刊文献+

厄贝沙坦和非洛地平控释片对高血压病人尿微量蛋白的影响 被引量:1

下载PDF
导出
摘要 目的:探讨降压药物厄贝沙坦和非洛地平控释片对高血压患者尿微量蛋白的影响。方法:将高血压伴有尿微量蛋白增高的病人随机分成两组,分别给予厄贝沙坦和非洛地平控释片治疗2个月,检测其治疗前后尿微量蛋白含量和血压,并进行比较。结果:两组均有较好的降压效果,无明显差别,但厄贝沙坦对改善尿微量蛋白的作用更加明显。非洛地平在本研究中未能发现上述作用。结论:厄贝沙坦能有效降低尿微量蛋白,保护肾脏靶器官,同时延缓高血压病人的血管损害。
作者 王曙
出处 《亚太传统医药》 2010年第6期121-122,共2页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献3

  • 1MURTAUGH M A,JACOBS D R JR.Correlates of urinary albumin exertion in young adult blacks[J].Epidemid,2003,158:676. 被引量:1
  • 2张素华.2型糖尿病与冠心病[J].辽宁实用糖尿病杂志,2001,9(4):1-4. 被引量:21
  • 3GOODFRIEND TL,ELLIOTT ME,CATT KJ.Drug therapy:angiotension recptors and their antagonists[J].N EngL J Med,1996334:1649-1655. 被引量:1

二级参考文献8

  • 1[1]Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart didease in subjects with type 2 diabetes and in non - diabetic subjects with and without prior myocardial infarction.The New England Journal of Medicaine 1998; 339: 229~ 234. 被引量:1
  • 2[2]Stamler J, Vaccaro ONeaton JD et al. Diabetes, other risk factor and 12 - yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434~ 444. 被引量:1
  • 3[3]Lamarche B, Tchemof A, Moorjanic S, et al. Small, dense low - density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997;95(1) :69~75. 被引量:1
  • 4[4]Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease .The New England Journal of Medicine 1996;334:952~ 957. 被引量:1
  • 5[5]Stehouwer CAD, NautaJJp, Zeldenrust GC, et al. Urinary albumi excretion, cardiovascular disease, non - insulin - dependent diabetes mellitus. Lancet 1992 ;41(suppl 2): 86~ 91. 被引量:1
  • 6[6]Turner R, CullC, Holman R et al. United Kingdom prospective diabetes study 17: A 9 - year update of a randomized,controlled trial on the effect of improved metabolic control on complications in non - insulin - dependent diabetes mellitus. Annals of internal medicaine 1996;124(1):136~145. 被引量:1
  • 7[7]American Diabetes Association Management of dyslipidemia in adults with diabetes. Diabetes Care 2000; 23 ( suppl 1):S1~S116. 被引量:1
  • 8[8]Sawicki PT, Berger M. Pharmacological treatment of diabetic patients with cardiovascular complications. [Review] Journal of Internal Medicine 1998;243(3):181~189. 被引量:1

共引文献20

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部